415 related articles for article (PubMed ID: 31681756)
1. Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects.
Gambacorta V; Gnani D; Vago L; Di Micco R
Front Cell Dev Biol; 2019; 7():207. PubMed ID: 31681756
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia.
Sun Y; Chen BR; Deshpande A
Front Oncol; 2018; 8():41. PubMed ID: 29527516
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
Eriksson A; Lennartsson A; Lehmann S
Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia.
Travaglini S; Gurnari C; Antonelli S; Silvestrini G; Noguera NI; Ottone T; Voso MT
Front Cell Dev Biol; 2022; 10():930205. PubMed ID: 35938170
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia.
Gallipoli P; Giotopoulos G; Huntly BJ
Ther Adv Hematol; 2015 Jun; 6(3):103-19. PubMed ID: 26137202
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Acute Myeloid Leukemia in the Era of Genomics-Achievements and Persisting Challenges.
Green SD; Konig H
Front Genet; 2020; 11():480. PubMed ID: 32536937
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations in acute myeloid leukemias.
Mehdipour P; Santoro F; Minucci S
FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
Yang X; Wong MPM; Ng RK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
Bewersdorf JP; Shallis R; Stahl M; Zeidan AM
Ther Adv Hematol; 2019; 10():2040620718816698. PubMed ID: 30719265
[TBL] [Abstract][Full Text] [Related]
10. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
[TBL] [Abstract][Full Text] [Related]
12. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.
Pan D; Rampal R; Mascarenhas J
Blood Adv; 2020 Mar; 4(5):970-982. PubMed ID: 32150613
[TBL] [Abstract][Full Text] [Related]
13. Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia.
Wingelhofer B; Somervaille TCP
Front Oncol; 2019; 9():850. PubMed ID: 31552175
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic targeting and personalized approaches for AML.
Roboz GJ
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia.
Lu R; Wang GG
Front Oncol; 2017; 7():241. PubMed ID: 29075615
[TBL] [Abstract][Full Text] [Related]
16. Role of epigenetic in leukemia: From mechanism to therapy.
Liu XL; Liu HQ; Li J; Mao CY; He JT; Zhao X
Chem Biol Interact; 2020 Feb; 317():108963. PubMed ID: 31978391
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation as a pathogenic event and as a therapeutic target in AML.
Schoofs T; Müller-Tidow C
Cancer Treat Rev; 2011; 37 Suppl 1():S13-8. PubMed ID: 21612874
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
Chianese U; Papulino C; Megchelenbrink W; Tambaro FP; Ciardiello F; Benedetti R; Altucci L
Semin Cancer Biol; 2023 Jul; 92():84-101. PubMed ID: 37003397
[TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
